Skip to main content
Equibles
LGND $283.95 -0.18%
LGND logo
LGND · Ligand Pharmaceuticals Inc
Track LGND — free

Use LGND with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LGND.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$283.95 -0.52 (-0.18%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$5.67B
Shares
19.94M
All earnings calls

Earnings call · FY2019 Q4

Ligand Pharmaceuticals Inc (LGND) Q4 2019 Earnings Call

Concluded Feb 6, 2020
Feb 6, 2020 0 turns
Period
FY2019 Q4
Runtime
—
Sources
2 artifacts
8-K 10-K

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $27.00M -54.7% YoY
Diluted EPS -$0.27
Net income -$7.37M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Feb 6, 2020 10-K report Filed Feb 27, 2020

Quarter detail

How the reported period landed and where the business moved.

Capital returned

Buybacks · derived
$81.94M
Full-screen source Call document

LGND transcript alerts

Ligand Pharmaceuticals Inc

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →